FDA vaccine chief leaving agency after less than 3 months
UNITED STATES, JUL 31 – Dr. Vinay Prasad resigned amid disputes over FDA gene therapy approvals and vaccine policies, facing criticism from political groups and a White House push, less than three months after his May 2025 appointment.
- Dr. Vinay Prasad stepped down from his position leading the FDA division responsible for vaccines and biologic medicines after serving less than three months.
- Prasad's departure followed a series of controversial decisions including FDA actions on a gene therapy for Duchenne muscular dystrophy and agency scrutiny of treatments.
- An HHS spokesperson stated that Prasad opted to move back to California to focus on his personal life and to avoid diverting attention from the FDA's efforts during the Trump administration.
- Right-Wing activist Laura Loomer recently accused Prasad on X of being a progressive leftist who is working against President Trump's FDA.
- Prasad's sudden exit marks an abrupt end to his tumultuous tenure, highlighting ongoing debates over FDA regulatory policies and leadership changes.
124 Articles
124 Articles
The Disgraceful Campaign Against a Top FDA Official
Three months ago, Dr. Marty Makary, the commissioner of the Food and Drug Administration, named Dr. Vinay Prasad to serve as the head of the FDA’s Center for Biologics Evaluation and Research, a division that “regulates biological products for human use” and oversees their safety and effectiveness. In making the announcement on X, he described his new hire, a well-known oncologist, Substacker, and frequent critic of the public-health establishme…
The polarizing head of vaccines of the Food and Drug Administration will leave the agency after a brief mandate that provoked the anger of biotechnology companies, patient groups, and conservative allies of President Donald Trump. Dr. Vinay Prasad “didn’t want to be a distraction” and resigned from his position as the FDA’s main vaccine regulator “to spend more time with his family,” a spokesman for the Department of Health and Human Services sa…
Coverage Details
Bias Distribution
- 65% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
